Valley Brook Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Valley Brook Capital Group's LLY Position: Q3 2026 in Review
Valley Brook Capital Group increased its Eli Lilly (LLY) stake by 0.31% in Q3 2026, buying an estimated $5.9K and bringing the position to 1,630 shares worth $1.89M. The position accounts for 1.06% of the portfolio, ranked #31.
Valley Brook Capital Group first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.95M in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Valley Brook Capital Group held 1,630 shares of Eli Lilly worth $1.89M as of Q3 2026.
- Valley Brook Capital Group bought 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
- Eli Lilly made up 1.06% of Valley Brook Capital Group's portfolio in Q3 2026, its #31 holding.
- Valley Brook Capital Group first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
- Valley Brook Capital Group's Eli Lilly position peaked at $1.95M in Q2 2026.
- 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Valley Brook Capital Group's 13F filing for Q3 2026, filed 26 Oct 2026.